Bioresorbable Scaffolds Market Scope
Growing incidence of cardiovascular diseases coronary, heart disease and ischaemic heart disease will help to boost the bioresorbable scaffolds market all over the world in the anticipated period. Bioresorbable scaffolds are the medical devices used during surgeries. Bioresorbable scaffolds are preferred over permanent implantation as they decrease device/host interaction, and requirement for long-term anti-coagulation therapy. Growing preference for vascular graft devices for angioplasty and coronary artery diseases is major factor driving bioresorbable scaffolds market.
The market study is being classified by Type (Synthetic and Biological), by Application (Coronary Artery Stents, Peripheral Artery Stents and Others) and major geographies with country level break-up. According to AMA, the Global Bioresorbable Scaffolds market is expected to see growth rate of 11.89% and may see market size of USD335.26 Million by 2024.
The Players having a strong hold in the market are 480 Biomedical, Abbott Laboratories, Amaranth Medical, Arterial Remodeling Technologies, and Arterius. Research Analyst at AMA predicts that United States and Chinese Players will contribute to the maximum growth of Global Bioresorbable Scaffolds market throughout the predicted period.
480 Biomedical (United States), Abbott Laboratories (United States), Amaranth Medical Inc. (Singapore), Arterial Remodeling Technologies (France), Arterius Limited (United Kingdom), BIOTRONIK (Germany), Boston Scientific Corporation (United States), Elixir Medical Corporation (United States), HangZhou HuaAn Biotechnology Co. Ltd. (China) and KYOTO MEDICAL PLANNING Co. Ltd. (Japan) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Lepu Medical Technology (Beijing) Co., Ltd. (China), Lifetech Scientific (Shenzhen) Co. Ltd (China), Manli Cardiology Ltd. (United States), Meril Life Sciences Pvt. Ltd. (India), OrbusNeich (hong Kong), Qualimed S.A.S. (France) and REVA Medical Inc. (United States).
AdvanceMarketAnalytics has segmented the market of Global Bioresorbable Scaffolds market by Type, Application and Region.
On the basis of geography, the market of Bioresorbable Scaffolds has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North Amercia region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by Material, the sub-segment i.e. Metal-based Bioresorbable Scaffold will boost the Bioresorbable Scaffolds market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Bioresorbable Scaffolds market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
On February 20, 2019, Abbott and Novo Nordisk have formed a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system. The partnership reflects both companies′ commitment to make diabetes management easier by connecting key technologies such as continuous glucose monitoring (CGM) and connected insulin pens.
- Introduction Preference for Vascular Graft Devices for Angioplasty and Coronary Artery Diseases
- Growing Adoption of Minimally Invasive Cardio Vascular Treatments
- Rising Prevalence of Coronary Heart Disease and Ischemic Heart Disease
- Growing Applications of Bioresorbable Stents by Physicians and Patients
- Upsurging Funding for Research and Development of Surgical Procedures
- Unfavorable Lifestyle Changes causing Obesity and Fatigue
- Skilled Physicians or Hospital Staff is required
- Lack of Healthcare Infrastructure and Ongoing Advancements in Underdeveloped Economies
- Introduction to New Players and Technological Existing is Viable to Threat of New Entrants
- Stringent Government Regulations related to Bioresorbable Scaffolds
Key Target AudienceBioresorbable Scaffolds Manufacturers, Bioresorbable Scaffolds Distributors and Traders, Hospitals and Clinics, Healthcare Industrial Associations, Government Agencies, Research and Development Organizations and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase